• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ERIKA DE REYNOSA, S.A. DE C.V. CUSTOM COMBI SET; SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE Back to Search Results
Catalog Number 03-2722-9
Device Problem Fluid/Blood Leak (1250)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 12/01/2017
Event Type  malfunction  
Manufacturer Narrative
Plant investigation: although it was initially stated that the complaint device was available to be returned to the manufacturer for physical evaluation, no sample has been received by the manufacturer for evaluation to date.As such, a definitive conclusion regarding the complaint incident cannot be reached without a physical examination of the complaint device.A records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There were no non-conformances or abnormalities identified during the manufacturing process which could be associated with the reported event.In addition, the dhr review confirmed the results of the in-progress and final quality control (qc) testing met all requirements.The lot met all specifications for release.A review of the dhr did not reveal a probable cause for the customer complaint.The reported complaint was not confirmed as the complaint device was not available for manufacturer evaluation.
 
Event Description
A user facility nurse manager reported that during a patient¿s hemodialysis (hd) treatment, approximately 2.5ml (milliliters) of blood leaked from the connection of the arterial portion of the fresenius bloodline which attaches to the catheter.This occurred approximately one hour twenty minutes after initiation of the patient¿s treatment.The hd machine did not alarm as there was no disruption in arterial pressure.It was reported that when the bloodline was removed from the catheter, there was a small crack visible in the bloodline.The treatment was interrupted, and the patient was set up with new supplies.The patient was given prophylactic antibiotic (vancomycin) medication and the results of the patient¿s hemoglobin remained unchanged from the blood loss.No patient adverse effects or injuries were experienced, and no medical intervention was required.The patient was able to complete treatment on the hd machine without any further interruptions or complications.The bloodline device was stated to be available to be returned to the manufacturer for physical evaluation.
 
Manufacturer Narrative
Additional information: device evaluation: the device was returned to the manufacturer for physical evaluation.The sample was received with a non-fresenius medical care north america (fmcna) connector attached to the venous and arterial patient end connector.A visual examination of the returned device found that the arterial patient end connector was within acceptable specifications for luer lock connectors and there were no observed cracks or defects, such as collar or taper damage.The male conical fitting of the arterial patient connector was dimensionally inspected using ansi male gauge iso 594/1 1986 (e), and the sample was found within the acceptable range.The visual inspection of the entire returned bloodline sample did not find any damage or irregularities.The sample was tested using a 2008t hemodialysis machine for simulated use.During the simulated use test, there were no observations of a leak, disconnection, air bubbles, and no level variation of the venous or arterial drip chambers or of any alarm.The device worked as intended with no noted abnormalities.The investigation into the cause of the reported problem was not able to confirm the reported leak.The testing of the returned sample could not reveal a probable cause for the customer complaint as the reported leak was not able to be duplicated.Therefore, the complaint is not confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CUSTOM COMBI SET
Type of Device
SET, TUBING, BLOOD, WITH AND WITHOUT ANTI-REGURGITATION VALVE
Manufacturer (Section D)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX  88780
Manufacturer (Section G)
ERIKA DE REYNOSA, S.A. DE C.V.
mike allen #1331
parque industrial reynosa
reynosa 88780
MX   88780
Manufacturer Contact
thomas c. johnson
920 winter st.
waltham, MA 02451
7816999499
MDR Report Key7142387
MDR Text Key95746761
Report Number8030665-2017-01151
Device Sequence Number1
Product Code FJK
UDI-Device Identifier00840861100293
UDI-Public00840861100293
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K962081
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 02/27/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue Number03-2722-9
Device Lot Number17HR01024
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/23/2018
Is the Reporter a Health Professional? Yes
Device Age MO
Date Manufacturer Received02/16/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/02/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-